Thu 26 Nov 2009 | 10:53 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Anadys Pharmaceuticals, Inc.

Anadys Pharmaceuticals, Inc. (ANDS.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View ANDS on other exchanges
As of  25 Nov 2009
2.15USD
Price Change
-0.04
Percent Change
-1.83%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Reed, Elizabeth 38 2006 Vice President - Legal Affairs, Corporate Secretary
Freddo, James 54 2008 Senior Vice President - Drug Development, Chief Medical Officer
Slover, Peter 34 2009 Principal Financial Officer, Vice President - Finance and Operations, Principal Accounting Officer
Worland, Stephen 51 2007 President, Chief Executive Officer, Director
Xanthopoulos, Kleanthis 50 2006 Director
Fotiadis, Marios 35 2002 Director
Papadopoulos, Stelios 60 2000 Director
Holtzman, Steven 55 2004 Director
Foletta, Mark 48 2005 Director
Scangos, George 60 2005 Chairman of the Board